These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15969573)
1. An efficient, stereocontrolled synthesis of a potent omuralide-salinosporin hybrid for selective proteasome inhibition. Reddy LR; Fournier JF; Subba Reddy BV; Corey EJ J Am Chem Soc; 2005 Jun; 127(25):8974-6. PubMed ID: 15969573 [TBL] [Abstract][Full Text] [Related]
2. Total synthesis of lactacystin and salinosporamide A. Shibasaki M; Kanai M; Fukuda N Chem Asian J; 2007 Jan; 2(1):20-38. PubMed ID: 17441136 [TBL] [Abstract][Full Text] [Related]
3. Total synthesis of (-)-salinosporamide A. Satoh N; Yokoshima S; Fukuyama T Org Lett; 2011 Jun; 13(12):3028-31. PubMed ID: 21591679 [TBL] [Abstract][Full Text] [Related]
4. A concise and straightforward total synthesis of (+/-)-salinosporamide A, based on a biosynthesis model. Mulholland NP; Pattenden G; Walters IA Org Biomol Chem; 2008 Aug; 6(15):2782-9. PubMed ID: 18633536 [TBL] [Abstract][Full Text] [Related]
5. Leaving groups prolong the duration of 20S proteasome inhibition and enhance the potency of salinosporamides. Manam RR; McArthur KA; Chao TH; Weiss J; Ali JA; Palombella VJ; Groll M; Lloyd GK; Palladino MA; Neuteboom ST; Macherla VR; Potts BC J Med Chem; 2008 Nov; 51(21):6711-24. PubMed ID: 18939815 [TBL] [Abstract][Full Text] [Related]
6. Nitrone [2+3]-cycloadditions in stereocontrolled synthesis of a potent proteasome inhibitor: (-)-omuralide. Legeay JC; Langlois N J Org Chem; 2007 Dec; 72(26):10108-13. PubMed ID: 18044922 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor. Macherla VR; Mitchell SS; Manam RR; Reed KA; Chao TH; Nicholson B; Deyanat-Yazdi G; Mai B; Jensen PR; Fenical WF; Neuteboom ST; Lam KS; Palladino MA; Potts BC J Med Chem; 2005 Jun; 48(11):3684-7. PubMed ID: 15916417 [TBL] [Abstract][Full Text] [Related]
8. Concise formal synthesis of (-)-salinosporamide A (marizomib) using a regio- and stereoselective epoxidation and reductive oxirane ring-opening strategy. Ling T; Potts BC; Macherla VR J Org Chem; 2010 Jun; 75(11):3882-5. PubMed ID: 20465296 [TBL] [Abstract][Full Text] [Related]
9. Enantioselective total synthesis of (-)-Salinosporamide A (NPI-0052). Ling T; Macherla VR; Manam RR; McArthur KA; Potts BC Org Lett; 2007 Jun; 9(12):2289-92. PubMed ID: 17497868 [TBL] [Abstract][Full Text] [Related]
10. Utility of the ammonia-free Birch reduction of electron-deficient pyrroles: total synthesis of the 20s proteasome inhibitor, clasto-lactacystin beta-lactone. Donohoe TJ; Sintim HO; Sisangia L; Ace KW; Guyo PM; Cowley A; Harling JD Chemistry; 2005 Jul; 11(14):4227-38. PubMed ID: 15864801 [TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition by a totally synthetic beta-lactam related to salinosporamide A and omuralide. Hogan PC; Corey EJ J Am Chem Soc; 2005 Nov; 127(44):15386-7. PubMed ID: 16262399 [TBL] [Abstract][Full Text] [Related]
12. Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors. Steverding D; Wang X; Potts BC; Palladino MA Planta Med; 2012 Jan; 78(2):131-4. PubMed ID: 22034066 [TBL] [Abstract][Full Text] [Related]
13. New synthetic route for the enantioselective total synthesis of salinosporamide A and biologically active analogues. Reddy LR; Fournier JF; Reddy BV; Corey EJ Org Lett; 2005 Jun; 7(13):2699-701. PubMed ID: 15957925 [TBL] [Abstract][Full Text] [Related]
14. A short, stereocontrolled, and practical synthesis of alpha-methylomuralide, a potent inhibitor of proteasome function. Saravanan P; Corey EJ J Org Chem; 2003 Apr; 68(7):2760-4. PubMed ID: 12662049 [TBL] [Abstract][Full Text] [Related]
15. Enantioselective total syntheses of belactosin A, belactosin C, and its homoanalogue. Larionov OV; de Meijere A Org Lett; 2004 Jun; 6(13):2153-6. PubMed ID: 15200308 [TBL] [Abstract][Full Text] [Related]
16. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one. Coutrot P; Claudel S; Didierjean C; Grison C Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473 [TBL] [Abstract][Full Text] [Related]
17. Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition. Groll M; McArthur KA; Macherla VR; Manam RR; Potts BC J Med Chem; 2009 Sep; 52(17):5420-8. PubMed ID: 19678642 [TBL] [Abstract][Full Text] [Related]
18. Total synthesis and structural confirmation of chlorodysinosin A. Hanessian S; Del Valle JR; Xue Y; Blomberg N J Am Chem Soc; 2006 Aug; 128(32):10491-5. PubMed ID: 16895415 [TBL] [Abstract][Full Text] [Related]
19. New entry to convertible isocyanides for the Ugi reaction and its application to the stereocontrolled formal total synthesis of the proteasome inhibitor omuralide. Gilley CB; Buller MJ; Kobayashi Y Org Lett; 2007 Aug; 9(18):3631-4. PubMed ID: 17672474 [TBL] [Abstract][Full Text] [Related]
20. Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome. Reed KA; Manam RR; Mitchell SS; Xu J; Teisan S; Chao TH; Deyanat-Yazdi G; Neuteboom ST; Lam KS; Potts BC J Nat Prod; 2007 Feb; 70(2):269-76. PubMed ID: 17243724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]